Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2015 Financial Results Teleconference and Webcast
Mar 02, 2016 07:00:00 (ET)
HENDERSON, Nev.--(BUSINESS WIRE)--March 02, 2016--
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced it will host a teleconference and webcast with management to discuss the fourth quarter and full year 2015 financial results, provide an update on the Company's business, and discuss expectations for the future.
Conference Call
MARQUIBO REVENUE INFO
Wednesday, March 9, 2016 @ 4:30 p.m. Eastern/1:30 p.m. Pacific
------------------------------------------------------------------------------
Domestic: (877) 837-3910, Conference ID# 51999726
International: (973) 796-5077, Conference ID# 51999726
For interested individuals unable to join the call, a replay will be available from March 9, 2016 @ 7:30 p.m. ET/4:30 p.m. PT through March 19, 2016 until 11:59 p.m. ET/8:59 p.m. PT.
Domestic Replay Dial-In (855) 859-2056, Conference ID# 51999726
#:
International Replay (404) 537-3406, Conference ID# 51999726
Dial-In #:
This conference call will also be webcast. Listeners may access the webcast, which will be available on the investor relations page of Spectrum Pharmaceuticals' website: www.sppirx.com on March 9, 2016 at 4:30 p.m. Eastern/1:30 p.m. Pacific.
